The Oncology Institute appoints Mark Stolper to its Board of Directors.
ByAinvest
Monday, Jan 5, 2026 8:35 am ET1min read
TOI--
Mark Stolper, a seasoned CFO, has joined the Board of Directors at The Oncology Institute, bringing significant public markets, financial, and operational leadership experience. Stolper previously served as Executive Vice President and CFO of RadNet since 2004 and has been a member of the Board of Directors for various healthcare companies, including 21st Century Oncology Holdings. His appointment is expected to enhance the company's expertise and strategic direction.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet